Search

everythinglearnresearchcommunity

for

Search:↓

Women under 55 with hair loss (AGA) may have a higher risk of heart disease (CAD).

No strong link between testosterone or DHEAS levels and acne or hair loss in females.

South Korean women with hair loss have lower hair density and thickness compared to healthy women.

The document explains how hair loss patterns in men and women, known as Androgenetic alopecia, are classified using the Hamilton-Norwood system for men and the Ludwig grade system for women.

The document explains how hair loss in men and women, known as Androgenetic alopecia, is categorized using the Hamilton-Norwood system for men and the Ludwig grade system for women.

Combination of minoxidil and finasteride is more effective in increasing hair diameter than minoxidil alone for female-pattern hair loss.

5% Azelaic acid is as effective as 2% Minoxidil for female pattern hair loss and could be an alternative for those allergic to Minoxidil or pregnant.

Trichoscopy is an effective, noninvasive method for early diagnosis of Female Pattern Hair Loss.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

New dermoscopic criteria accurately diagnose and grade the severity of hair loss in androgenetic alopecia.

Platelet-rich plasma injections significantly improve hair density and thickness in both male and female pattern hair loss, especially in early stages.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

Higher concentration of botulinum toxin A is safe and effective for treating hair loss in men and women.

Trichoscopy effectively diagnoses early female hair loss, but may need scalp biopsy for confirmation.

The antiandrogen 11α-hydroxyprogesterone effectively reduces skin oil and cholesterol when applied to the skin.

Many COVID-19 survivors experience long-term symptoms but still report satisfactory quality of life and return to work.

Ozenoxacin 1% cream is an effective and safe treatment for impetigo in children and adults.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

The BASP classification is a detailed and accurate way to categorize hair loss in both men and women.

Finasteride improves hair density and thickness in women with hair loss.

Growth factors and microneedle therapy increase hair density in women with hair loss.

Some psychiatric drugs can cause severe hair loss, especially valproic acid, and it's more likely in women or those with thyroid issues or past hair loss.

"Male-pattern" hair loss is common in women, especially after menopause, and doesn't always mean there's a problem with hormone balance.

Using human fat tissue derived stem cells in micrografts can safely and effectively increase hair density in people with hair loss.

Japanese women typically start experiencing hair loss after 40, with reduced hair density and thickness being the main factors.

Female pattern hair loss can be treated with medications, surgery, and cosmetic products, considering its psychological impact.

Finasteride can slow hair loss and promote growth in postmenopausal women.

The hair shedding scale accurately identifies abnormal hair shedding in women with long hair, with grades 5 and 6 indicating excessive shedding.

Acne severity in women may not be linked to increased male hormone indicators like excess body hair, menstrual irregularities, or hair loss.

The BASP classification is more reliable than the Norwood-Hamilton for classifying hair loss in men and women.